dalteparin has been researched along with Anasarca in 22 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We showed that both enoxaparin and hesperidin exerted significant preventive effects in all the parameters related to acute pancreatitis in our experimental rat model." | 7.79 | Preventive effects of enoxaparin and hesperidin in cerulein-induced acute pancreatitis in rats. ( Akyildiz Iğdem, A; Köksoy, FN; Őzkan Gūrdal, S; Şen Oran, E; Soybir, GR; Yankol, Y; Yildirim Yazgan, N; Yūksel, M, 2013) |
| "In this pilot study, there was no clinically relevant difference in anti-Xa activity after subcutaneous administration of 2,500 IU dalteparin for venous thromboembolism prophylaxis between ICU patients with and without subcutaneous oedema." | 7.73 | Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. ( Egberts, TC; Rommers, MK; van den Bemt, PM; Van der Lely, N, 2006) |
| "We showed that both enoxaparin and hesperidin exerted significant preventive effects in all the parameters related to acute pancreatitis in our experimental rat model." | 3.79 | Preventive effects of enoxaparin and hesperidin in cerulein-induced acute pancreatitis in rats. ( Akyildiz Iğdem, A; Köksoy, FN; Őzkan Gūrdal, S; Şen Oran, E; Soybir, GR; Yankol, Y; Yildirim Yazgan, N; Yūksel, M, 2013) |
| "In this pilot study, there was no clinically relevant difference in anti-Xa activity after subcutaneous administration of 2,500 IU dalteparin for venous thromboembolism prophylaxis between ICU patients with and without subcutaneous oedema." | 3.73 | Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. ( Egberts, TC; Rommers, MK; van den Bemt, PM; Van der Lely, N, 2006) |
| "With patients in whom it is indicated, the home therapy ankle pathway has proved to be a safe and resource sparing method of managing ankle fractures prior to surgery." | 1.39 | Home therapy pathway - safe and streamlined method of initial management of ankle fractures. ( Baraza, N; Dhukaram, V; Lever, S, 2013) |
| "Two cohorts of critically ill multiple trauma patients were enrolled in this study: A (nonedematous) and B (edematous, defined as the presence of peripheral edema and an increase in body weight of > or =10 kg)." | 1.33 | Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients. ( Beres, J; Forrest, A; Haas, CE; Ma, Q; Mihalko, W; Nelsen, JL; Raghavendran, K, 2005) |
| "Pretreatment with indomethacin completely reversed both of the therapeutic effects of dalteparin, whereas pretreatment with NS-398, a selective inhibitor of cyclooxygenase-2, did not." | 1.33 | Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. ( Harada, N; Okajima, K; Uchiba, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Adişen, E | 1 |
| Seker, U | 1 |
| Gürer, MA | 1 |
| Maradei-Pereira, JAR | 3 |
| Sauma, ML | 3 |
| Demange, MK | 3 |
| Lal, S | 1 |
| Hashmi, J | 1 |
| Vicci, H | 1 |
| Eblen-Zajjur, A | 1 |
| López, M | 1 |
| Crespo, G | 1 |
| Navarro, M | 1 |
| Kim, BY | 1 |
| Moon, AS | 1 |
| Vasquez, R | 1 |
| Warrier, R | 2 |
| Alva, H | 1 |
| Goyeneche, N | 1 |
| Fletcher, M | 1 |
| Baraza, N | 1 |
| Lever, S | 1 |
| Dhukaram, V | 1 |
| Köksoy, FN | 1 |
| Yankol, Y | 1 |
| Şen Oran, E | 1 |
| Őzkan Gūrdal, S | 1 |
| Yūksel, M | 1 |
| Akyildiz Iğdem, A | 1 |
| Yildirim Yazgan, N | 1 |
| Soybir, GR | 1 |
| Martí-Gamboa, S | 1 |
| Savirón Cornudella, R | 1 |
| Campillos-Maza, JM | 1 |
| Sauer, S | 1 |
| Goltz, JP | 1 |
| Gassenmaier, T | 1 |
| Kunz, AS | 1 |
| Bley, TA | 1 |
| Klein, D | 1 |
| Petritsch, B | 1 |
| Pruitt, LG | 1 |
| Mosley, JC | 1 |
| Lasseigne, RF | 1 |
| Khalafallah, AA | 1 |
| Renu, S | 1 |
| Sharp, C | 1 |
| Hannan, T | 1 |
| Röttger, C | 1 |
| Madlener, K | 1 |
| Heil, M | 1 |
| Gerriets, T | 1 |
| Walberer, M | 1 |
| Wessels, T | 1 |
| Bachmann, G | 1 |
| Kaps, M | 1 |
| Stolz, E | 1 |
| Haas, CE | 1 |
| Nelsen, JL | 1 |
| Raghavendran, K | 1 |
| Mihalko, W | 1 |
| Beres, J | 1 |
| Ma, Q | 1 |
| Forrest, A | 1 |
| Har-Noy, O | 1 |
| Meltzer, E | 1 |
| Alli, NA | 1 |
| Wainwright, RD | 1 |
| Mackinnon, D | 1 |
| Poyiadjis, S | 1 |
| Naidu, G | 1 |
| Fazel, R | 1 |
| Froehlich, JB | 1 |
| Williams, DM | 1 |
| Saint, S | 1 |
| Nallamothu, BK | 1 |
| Olmarker, K | 1 |
| Rydevik, B | 1 |
| Takikawa, M | 1 |
| Nakamura, S | 1 |
| Ishihara, M | 2 |
| Takabayashi, Y | 1 |
| Fujita, M | 1 |
| Hattori, H | 1 |
| Kushibiki, T | 1 |
| Harada, N | 1 |
| Okajima, K | 1 |
| Uchiba, M | 1 |
| Rommers, MK | 1 |
| Van der Lely, N | 1 |
| Egberts, TC | 1 |
| van den Bemt, PM | 1 |
| How, P | 1 |
| Cheng, KS | 1 |
| Sridhar, P | 1 |
| Hamilton, HE | 1 |
2 reviews available for dalteparin and Anasarca
| Article | Year |
|---|---|
[Massive gestational vulvar edema. A case report and review of literature].
Topics: Albumins; Anti-Infective Agents; Anticoagulants; Cesarean Section; Edema; Enoxaparin; Exudates and T | 2014 |
Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature.
Topics: Anemia, Sickle Cell; Anticoagulants; Catheterization; Child; Diagnosis, Differential; Edema; Enoxapa | 2007 |
1 trial available for dalteparin and Anasarca
| Article | Year |
|---|---|
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Edema; Enoxaparin; Humans; Postoperative Com | 2022 |
19 other studies available for dalteparin and Anasarca
| Article | Year |
|---|---|
Rare cause of abdominal swelling and edema: iliac vein thrombosis.
Topics: Abdomen; Adult; Anticoagulants; Edema; Female; Humans; Iliac Vein; Magnetic Resonance Imaging; Nadro | 2009 |
A Rare Finding of Upper Limb Deep Venous Thrombosis in a Patient with COVID-19.
Topics: Anticoagulants; Arm; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Edema; Enoxaparin; | 2020 |
Enoxaparin pretreatment effect on local and systemic inflammation biomarkers in the animal burn model.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Antithrombin III; Biomarkers; Burns; C-Reactive P | 2019 |
Acute Onset of Unilateral Edema of Leg Followed by Hemiplegia in an Adolescent: A Case Report.
Topics: Adolescent; Angioplasty; Anticoagulants; Balloon Valvuloplasty; Diagnosis, Differential; Edema; Enox | 2018 |
Sports Injury or Venous Thrombosis?
Topics: Adolescent; Anticoagulants; Arm; Arthralgia; Athletic Injuries; Compression Bandages; Diagnosis, Dif | 2019 |
Home therapy pathway - safe and streamlined method of initial management of ankle fractures.
Topics: Adult; Aged; Aged, 80 and over; Ankle Injuries; Anticoagulants; Case-Control Studies; Casts, Surgica | 2013 |
Preventive effects of enoxaparin and hesperidin in cerulein-induced acute pancreatitis in rats.
Topics: Acute Disease; Amylases; Animals; Anticoagulants; Antioxidants; Ceruletide; Edema; Enoxaparin; Hespe | 2013 |
Partial segmental thrombosis of the corpus cavernosum (PSTCC) diagnosed by contrast-enhanced ultrasound: a case report.
Topics: Adult; Anticoagulants; Aspirin; Contrast Media; Edema; Enoxaparin; Humans; Male; Pain; Penile Diseas | 2014 |
Bacteremia and Deep Vein Thrombosis in an Infant.
Topics: Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Clindamycin; Edema; Emergency Servic | 2016 |
Extensive venous thrombosis in a healthy young man with a short inferior vena cava syndrome treated successfully with rivaroxaban.
Topics: Adult; Anticoagulants; Edema; Enoxaparin; Humans; Iliac Vein; Incidental Findings; Male; Morpholines | 2012 |
Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
Topics: Abciximab; Angiography; Animals; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Chlorides; | 2005 |
Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Cohort Studies; Critical Illness; Edema; Enoxapari | 2005 |
Upper-extremity deep-vein thrombosis in an elderly man.
Topics: Aged; Anticoagulants; Arm; Chest Pain; Dyspnea; Edema; Enoxaparin; Exercise; Factor V; Humans; Male; | 2007 |
Clinical problem-solving. A sinister development--a 35-year-old woman presented to the emergency department with a 2-day history of progressive swelling and pain in her left leg, without antecedent trauma.
Topics: Adult; Anticoagulants; Constriction, Pathologic; Contraceptives, Oral; Edema; Enoxaparin; Female; Fi | 2007 |
Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica.
Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Antirheumatic Agents; Cauda Equina; Edema; Enoxapar | 2001 |
Improved angiogenesis and healing in crush syndrome by fibroblast growth factor-2-containing low-molecular-weight heparin (Fragmin)/protamine nanoparticles.
Topics: Animals; Anticoagulants; Crush Syndrome; Dalteparin; Disease Models, Animal; Drug Evaluation, Precli | 2015 |
Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anticoagulants; Calcium; Cyclooxygenase 2 Inhibitors; Daltepa | 2006 |
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Dalteparin; Edema; Factor Xa; Factor Xa Inhibitors; | 2006 |
Ruptured 'fem-pop' vein graft presenting as deep venous thrombosis.
Topics: Aged, 80 and over; Aneurysm, False; Aortic Dissection; Blood Vessel Prosthesis; Diagnostic Errors; E | 2004 |